AMBALAL SARABHAI ENTERPRISES
Back to Balance Sheet
|
AMBALAL SARABHAI ENTERPRISES Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹39 Cr | ₹35 Cr | ₹29 Cr | ₹32 Cr | ₹35 Cr |
What is the latest Contingent Liabilities ratio of AMBALAL SARABHAI ENTERPRISES ?
| Year | Contingent Liabilities |
|---|---|
| Mar2026 | ₹39 Cr |
| Mar2025 | ₹35 Cr |
| Mar2024 | ₹29 Cr |
| Mar2023 | ₹32 Cr |
| Mar2022 | ₹35 Cr |
How is Contingent Liabilities of AMBALAL SARABHAI ENTERPRISES Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹39 Cr | 10.69 | |
| Mar2025 | ₹35 Cr | 22.25 | |
| Mar2024 | ₹29 Cr | -11.91 | |
| Mar2023 | ₹32 Cr | -8.19 | |
| Mar2022 | ₹35 Cr | - | |
Compare Contingent Liabilities of peers of AMBALAL SARABHAI ENTERPRISES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AMBALAL SARABHAI ENTERPRISES | ₹237.2 Cr | -0.9% | -4.9% | -14.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹463,815.0 Cr | 0.5% | 6.2% | 17.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹192,678.0 Cr | 4.7% | 9% | 7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹161,323.0 Cr | -3.7% | 7.2% | 49.8% | Stock Analytics | |
| CIPLA | ₹114,585.0 Cr | -0.6% | 5% | -3.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,067.0 Cr | -1.9% | -4.6% | -2.8% | Stock Analytics | |
AMBALAL SARABHAI ENTERPRISES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AMBALAL SARABHAI ENTERPRISES | -0.9% |
-4.9% |
-14.7% |
| SENSEX | 0.8% |
1.8% |
-6.5% |
You may also like the below Video Courses